<DOC>
	<DOC>NCT00288249</DOC>
	<brief_summary>The purpose of this study is to determine whether the study drug is effective and safe in the treatment of patients with metastatic breast cancer</brief_summary>
	<brief_title>Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Metastatic breast cancer No previous treatment with taxanes, and vinca alkaloids Use of highly effective birth control methods in females of childbearing potential More than 2 previous chemotherapies Previous participation in another trial within the last 4 weeks Breast feeding Active infections</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Breast Neoplasms</keyword>
</DOC>